Page last updated on July 16, 2024
FibroBiologics, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-02-29 17:09:30 EST.
Filings
10-K filed on 2024-02-29
FibroBiologics, Inc. filed a 10-K at 2024-02-29 17:09:30 EST
Accession Number: 0001493152-24-008361
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Item 1C. Cybersecurity Risk Management and Strategy We have processes for assessing, identifying and managing cybersecurity risks, which are an integral part of decision-making at every level. Such processes include physical, procedural and technical safeguards, response plans, and routine review of our policies and procedures to identify risks and refine our practices. We have engaged an external Information Technology Managed Service Provider, or IT MSP, to help our management team design, implement and maintain our information technology systems and infrastructure. Members of our executive leadership team provide oversight of the activities of the IT MSP to ensure appropriate controls. Furthermore, the Audit Committee has oversight with respect to our internal controls and managing the risks of cybersecurity threats. Governance Our Audit Committee of the Board of Directors is responsible for overseeing cybersecurity risk and periodically updates our Board of Directors on such matters. The Audit Committee receives periodic updates from management regarding cybersecurity matters and is notified between such updates regarding any significant new cybersecurity threats or incidents. We do not believe that there are currently any known risks from cybersecurity threats that are reasonably likely to materially affect us or our business strategy, results of operations or financial condition, and have not had previous cybersecurity incidents that have materially affected us.
Company Information
Name | FibroBiologics, Inc. |
CIK | 0001958777 |
SIC Description | Pharmaceutical Preparations |
Ticker | FBLG - null |
Website | |
Category | Emerging growth company |
Fiscal Year End | December 30 |